

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Pectolinarigenin, a natural product isolated and purified from the herbs of Cirsium japonicum DC., possesses hepatoprotective and anti-inflammatory activity. |
| Concentration | Treated Time | Description | References | |
| Staphylococcus aureus | 0.39 μg/mL (IC50) | 24 hours | Inhibited biofilm formation | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| Streptococcus sobrinus | 1.4 μg/mL (IC50) | 24 hours | Inhibited biofilm formation | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| Streptococcus mutans | 1.2 μg/mL (IC50) | 24 hours | Inhibited biofilm formation | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| Escherichia coli | 0.25 μg/mL (IC50) | 24 hours | Inhibited biofilm formation | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| Enterococcus faecium | 0.19 μg/mL (IC50) | 24 hours | Inhibited biofilm formation | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| Enterococcus faecalis | 0.39 μg/mL (IC50) | 24 hours | Inhibited biofilm formation | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| T24 cells | 0.01–50 μg/mL | 24 hours | Reduced bacterial adherence | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| Porphyromonas gingivalis | 9.0 μg/mL (IC50) | 24 hours | Inhibited biofilm formation | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| Cutibacterium acnes | 12.5 μg/mL (IC50) | 24 hours | Inhibited biofilm formation | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| Pseudomonas aeruginosa | 0.9 μg/mL (IC50) | 24 hours | Inhibited biofilm formation | Antibiotics (Basel). 2022 Apr 29;11(5):598 |
| SARS-CoV 3CLpro | 37.78 µM | 16 hours | Inhibition of SARS-CoV 3CLpro enzymatic activity | J Enzyme Inhib Med Chem. 2020 Dec;35(1):145-151 |
| L-929 fibroblasts | 20 μg/mL | 2 hours | Evaluate the antioxidant capacity of Pectolinarin, results showed that 20 μg/mL of Pectolinarin effectively counteracted the detrimental effects of reactive oxygen species (ROS). | J Cell Mol Med. 2024 Feb;28(4):e18130 |
| SH-SY5Y neuronal cells | 1, 2.5, 5, 10 µg/mL | 24 hours | To investigate the protective effects of Pectolinarin against H2O2-induced oxidative stress. Results showed that Pectolinarin significantly increased cell viability and reduced ROS production and LDH release. | Molecules. 2023 Aug 2;28(15):5826 |
| EA.hy926 endothelial cells | 25, 50, 100, 200 μg/mL | 24, 48, 72 hours | Assess the effect of Pectolinarin on endothelial cell proliferation, results showed that 50 μg/mL of Pectolinarin significantly promoted endothelial cell proliferation. | J Cell Mol Med. 2024 Feb;28(4):e18130 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 female mice | Ovariectomy model | Oral | 20 mg/kg | Once daily for 8 weeks | To evaluate the protective effects of Pectolinarin on ovariectomy-induced osteoporosis, results showed Pectolinarin inhibited bone resorption and promoted bone formation. | Int J Mol Sci. 2023 Jan 13;24(2):1620 |
| Mice | LPS-induced acute liver and kidney injury model | Intraperitoneal injection | 25 mg/kg and 50 mg/kg | Once daily for 3 days | To evaluate the protective effect of Pectolinarin on LPS-induced acute liver and kidney injury. Results showed that Pectolinarin significantly alleviated histopathological injuries in liver and kidney and reduced serum TNF-α levels. | Molecules. 2022 Dec 8;27(24):8695 |
| Sprague Dawley (SD) rats | Full-thickness skin defect model | Topical administration | 50 μg/mL | Replenished every 3 days for 14 days | Evaluate the effect of Pectolinarin hydrogel on wound healing and scar formation, results showed that 50 μg/mL of Pectolinarin hydrogel significantly promoted wound healing and minimized scar formation. | J Cell Mol Med. 2024 Feb;28(4):e18130 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.61mL 0.32mL 0.16mL |
8.03mL 1.61mL 0.80mL |
16.06mL 3.21mL 1.61mL |
|
| CAS号 | 28978-02-1 |
| 分子式 | C29H34O15 |
| 分子量 | 622.57 |
| SMILES Code | O=C1C=C(C2=CC=C(OC)C=C2)OC3=CC(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]5[C@@H]([C@@H]([C@H]([C@H](C)O5)O)O)O)O4)O)O)O)=C(OC)C(O)=C13 |
| MDL No. | MFCD12407436 |
| 别名 | 大蓟苷 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 30 mg/mL(48.19 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1